V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009279 | 310004226 | 1.68 | 132.8 | Palliative (P) | 2015-12-31 | 2016-01-22 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015305 | CISPLATIN + GEMCITABINE |
| 310009280 | 310004227 | 1.67 | 70 | Disease modification (D) | 2017-10-03 | 2017-10-06 | GEM-P | 02 | N | 310015321 | GEMCITABINE + PACLITAXEL |
| 310009281 | 310011218 | 1.64 | 68 | Palliative (P) | 2019-03-05 | 2019-03-05 | CISPLATIN + GEMCITABINE | 02 | N | 310015328 | CISPLATIN + GEMCITABINE |
| 310009282 | 310004230 | 1.64 | 61.5 | null | 2019-01-13 | 2019-02-06 | Brentuximab | N | N | 310015333 | BRENTUXIMAB |
| 310009283 | 310004231 | 1.54 | 61.2 | Palliative (P) | 2019-03-07 | 2019-03-10 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310015337 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009284 | 310004231 | 1.9 | null | Curative (C) | 2016-05-21 | 2016-05-29 | GEM-P | N | N | 310015337 | GEMCITABINE + PACLITAXEL |
| 310009285 | 310004233 | null | 83.2 | Palliative (P) | 2017-01-02 | 2017-01-03 | PEMBROLIZUMAB | N | N | 310015359 | PEMBROLIZUMAB |
| 310009286 | 310004235 | 1.6 | 84.3 | Palliative (P) | 2010-06-10 | 2013-10-14 | CISPLATIN + GEMCITABINE | 2 | N | 310015360 | CISPLATIN + GEMCITABINE |
| 310009287 | 310004235 | null | 18 | Curative (C) | 2016-01-06 | 2016-06-22 | GEM-P | 02 | N | 310015360 | GEMCITABINE + PACLITAXEL |
| 310009288 | 310004238 | 1.86 | 91.9 | null | 2015-12-18 | 2016-01-19 | CISPLATIN + GEMCITABINE | 02 | N | 310015378 | CISPLATIN + GEMCITABINE |
| 310009289 | 310004244 | 1.75 | 117.6 | null | 2017-04-06 | 2017-04-12 | Brentuximab | N | N | 310015424 | BRENTUXIMAB |
| 310009290 | 310004244 | 1.55 | 47 | Palliative (P) | 2017-05-11 | 2017-05-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310015424 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009291 | 310004244 | 1.74 | null | Curative (C) | 2015-11-14 | 2015-11-16 | IVE | 02 | null | 310015424 | IVE |
| 310009292 | 310004247 | 1.28 | 55.5 | Disease modification (D) | 2013-11-13 | 2013-11-13 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | 310015446 | NOT MATCHED |
| 310009293 | 310004250 | 1.75 | 92 | Disease modification (D) | 2017-11-30 | 2018-05-19 | LEAM | 02 | N | 310015462 | LEAM |
| 310009294 | 310004253 | 1.68 | 55.3 | Not known (9) | 2019-01-11 | 2019-02-07 | IVE | 02 | N | 310015475 | IVE |
| 310009295 | 310004255 | 1.54 | 86 | Palliative (P) | 2015-05-14 | 2015-09-05 | Carboplatin + Liposomal Doxorubicin | N | N | 310015480 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009296 | 310004257 | 1.7 | 79.1 | Curative (C) | 2014-07-14 | 2014-07-21 | LEAM | 2 | N | 310015487 | LEAM |
| 310009297 | 310004260 | 1.71 | 94 | Curative (C) | null | 2016-05-31 | LEAM | 02 | null | 310015518 | LEAM |
| 310009298 | 310010648 | 1.74 | null | Palliative (P) | 2014-09-26 | 2014-09-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310015581 | GEMCITABINE |
| 310009299 | 310004262 | 1.8 | 61.6 | Curative (C) | null | 2015-12-31 | IVE | 02 | N | 310015581 | IVE |
| 310009300 | 310004264 | 1.69 | 94.3 | Curative (C) | 2018-08-03 | 2018-08-06 | BEAM | 02 | N | 310015599 | BEAM |
| 310009301 | 310011530 | 1.9 | 94 | null | 2018-09-19 | 2018-11-14 | PEMBROLIZUMAB | N | N | 310015613 | PEMBROLIZUMAB |
| 310009302 | 310004265 | 1.73 | null | Curative (C) | 2015-12-12 | 2015-12-12 | BEAM | N | N | 310015639 | BEAM |
| 310009303 | 310004267 | 1.74 | 14 | Palliative (P) | 2017-02-20 | 2017-07-14 | GEM-P | null | null | 310015654 | GEMCITABINE + PACLITAXEL |
| 310009304 | 310007782 | null | 0 | Curative (C) | 2017-05-09 | 2017-05-10 | PEMBROLIZUMAB | N | N | 310015670 | PEMBROLIZUMAB |
| 310009305 | 310011531 | null | 62.8 | Palliative (P) | 2016-09-09 | 2016-09-23 | Brentuximab | N | null | 310015687 | BRENTUXIMAB |
| 310009306 | 310004274 | null | 62.5 | Palliative (P) | 2014-10-11 | 2014-10-21 | GEMCITABINE | N | N | 310015755 | GEMCITABINE |
| 310009307 | 310004275 | 1.72 | 58.4 | null | 2016-12-02 | 2016-12-03 | Brentuximab | 02 | null | 310015755 | BRENTUXIMAB |
| 310009308 | 310004278 | 1.78 | 49.5 | Palliative (P) | null | 2013-03-26 | GEM-P | N | N | 310015793 | GEMCITABINE + PACLITAXEL |
| 310009309 | 310004280 | null | 73 | Palliative (P) | 2013-10-29 | 2013-11-19 | PEMBROLIZUMAB | 2 | N | 310015845 | PEMBROLIZUMAB |
| 310009310 | 310004282 | 1.78 | 68 | Palliative (P) | 2014-09-22 | 2014-11-04 | Carboplatin + Liposomal Doxorubicin | N | N | 310015863 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009311 | 310007790 | 1.79 | 72 | Palliative (P) | 2014-01-15 | 2014-01-22 | PEMBROLIZUMAB | N | N | 310015877 | PEMBROLIZUMAB |
| 310009312 | 310004286 | 1.81 | 130 | Palliative (P) | 2018-03-23 | 2018-04-13 | CISPLATIN + GEMCITABINE | N | N | 310015897 | CISPLATIN + GEMCITABINE |
| 310009313 | 310004287 | 1.62 | 73.4 | Palliative (P) | null | 2014-04-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310015911 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009314 | 310004287 | 0 | 57 | Curative (C) | 2018-09-15 | 2018-09-23 | STS Rhabdomyosarco RMS 2005 IVADoVV | 2 | N | 310015911 | NOT MATCHED |
| 310009315 | 310004290 | 1.83 | 82 | Curative (C) | 2016-11-20 | 2016-11-20 | LEAM | N | N | 310015971 | LEAM |
| 310009316 | 310004292 | 1.57 | null | null | 2015-07-27 | 2015-07-29 | LEAM | 02 | N | 310015985 | LEAM |
| 310009317 | 310004295 | 1.68 | 13.5 | Curative (C) | 2017-01-14 | 2017-01-15 | IVE | N | N | 310016025 | IVE |
| 310009318 | 310007795 | 1.71 | 58.4 | Palliative (P) | null | 2018-07-12 | PEMBROLIZUMAB | N | N | 310016049 | PEMBROLIZUMAB |
| 310009319 | 310004300 | 1.64 | null | Palliative (P) | 2017-08-13 | 2017-08-13 | Brentuximab | 2 | N | 310016050 | BRENTUXIMAB |
| 310009320 | 310009662 | 1.67 | 98 | Palliative (P) | 2014-07-01 | 2014-07-02 | Brentuximab | N | N | 310016068 | BRENTUXIMAB |
| 310009321 | 310004303 | 1.52 | 52.4 | Curative (C) | 2014-04-19 | 2014-04-19 | Mini BEAM | 02 | N | 310016112 | BEAM |
| 310009322 | 310004306 | 1.74 | 74 | Curative (C) | 2017-11-16 | 2017-11-20 | BEAM | N | N | 310016118 | BEAM |
| 310009323 | 310004307 | 1.51 | 111.9 | Palliative (P) | 2018-06-27 | 2018-08-24 | Brentuximab | N | N | 310016129 | BRENTUXIMAB |
| 310009324 | 310004309 | 1.49 | 78.6 | Palliative (P) | 2018-02-27 | 2018-03-10 | Carboplatin + Liposomal Doxorubicin | N | N | 310016135 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009325 | 310004310 | 1.54 | 24.9 | Disease modification (D) | 2015-04-07 | 2015-04-17 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016142 | CISPLATIN + GEMCITABINE |
| 310009326 | 310010658 | 1.5 | 50.8 | null | 2014-03-10 | 2014-03-11 | IVE | N | null | 310016157 | IVE |
| 310009327 | 310007802 | null | null | Disease modification (D) | 2013-03-26 | 2014-07-01 | Brentuximab Vedotin | N | N | 310016192 | BRENTUXIMAB |
| 310009328 | 310004314 | 1.65 | 56.4 | Palliative (P) | 2018-02-07 | 2018-09-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310016209 | CARBOPLATIN + LIPOSOMAL DOX |